56
Addressing Substance Abuse
David Vlahov
New York Academy of Med, NY, US
Background: Among HIV researchers and clinicians,
“drug use” has long been a code word for injection drug use (IDU); this is due
in part to the early decision to report AIDS cases within hierarchical
categories that were interpreted as independent, non-overlapping and
exhaustive. That decision was enhanced with creation of the categorical funding
streams (i.e., NIDA, NIAID, NIMH). The categories revealed a class-based
distinction (race, education, income) that may have further dampened a
concerted response to the effects of substance use on other HIV risk behaviors.
An unfortunate consequence has been the delay in fully addressing non-injection
substance use as an important influence on sexual risk for HIV transmission.
Until recently, substance abuse HIV prevention has focused primarily on
injection (rather than drug) related behavior, centered on a comprehensive
approach to injection drug use involving drug abuse treatment, syringe access,
and other behavioral, social, and environmental interventions. Multiple cities
now report that HIV rates in IDU have been lowered to rates equal to non-IDU.
The remaining challenge is addressing sex risk, including the established role
of non-injected substances (cocaine/crack, club drugs including
methamphetamine, inhaled heroin, abused prescription drugs, and alcohol).
Conclusions: The successful introduction of
buprenorphine has expanded the availability of opioid treatment and has been
shown to be effective in HIV risk reduction and appropriate for those abusing
prescription analgesics. While pharmacological advances for stimulant abuse
have been limited, there is evidence suggesting benefits of behavioral
therapies. For occasional users, brief, office-based, and other low-threshold
interventions have demonstrated efficacy, whereas more extensive
approaches—such as cognitive behavioral therapy, motivational interviewing, and
contingency management—have been successful for dependent users. Research on
mechanisms of how drugs influence sex risk will contribute to shaping the
content of interventions. Moving forward, research and practice need to better
embrace authentic multi-disciplinary perspectives that include greater emphasis
on substance abuse issues.
|